Posts

Showing posts matching the search for space stocks

AST SpaceMobile vs. Rocket Lab: A Tale of Two Space Stocks

Image
AST SpaceMobile vs. Rocket Lab: A Tale of Two Space Stocks THE MONEYWISE JOURNAL  ·  finance  ·  Sunday, August 09, 2026 ASTS is focused on connecting ordinary smartphones from orbit, while RKLB is building a diversified space platform. By MoneyWise Guide As of August 4, 2026, two space stocks, AST SpaceMobile (ASTS) and Rocket Lab (RKLB), have been making headlines in the satellite communications market. ASTS is focused on connecting ordinary smartphones from orbit, while RKLB is building a diversified space platform. The ability to convert ambitious networks into recurring cash flow could determine which stock creates more long-term value. Key Takeaways ASTS stock price increased by 6.80% on August 4, 2026. RKLB stock price increased by 9.46% on August 4, 2026. Both companies are pursuing different strategies in the satellite communications market. Metric Value Why it matters ASTS St...

Chinese Chip Stocks Slump as Investors Rotate Away From Tech

Image
Chinese tech stocks plunged on Thursday, led by high-flying semiconductor names, as concerns over stretched valuations and crowded positioning intensified a rotation out of some of this year’s best-performing sectors. What's Behind the Plunge in Chinese Chip Stocks? As the tech sector continues to experience a rotation, Chinese chip stocks have been among the hardest hit. The sector has been driven by high-growth companies, particularly in the semiconductor space. However, as investors begin to rotate out of these companies, the sector is experiencing a significant decline. One of the primary concerns driving the rotation is valuation. Many of the high-growth companies in the sector have seen their valuations skyrocket in recent years, leading to concerns that they are overvalued. Additionally, the crowded positioning in the sector has led to increased volatility, making it a riskier investment for many. Another factor contributing to the decline is the shift in investor se...

MSFT vs. META pair trade: Divergence confirmed, entry timing complicated

Image
As an investor, you're always on the lookout for opportunities to grow your portfolio. One popular strategy is pair trading, which involves combining two stocks with a strong historical correlation to profit from their relative price movements. In this article, we'll explore the MSFT vs. META pair trade, a popular combination that has seen its fair share of ups and downs. We'll delve into the divergence between these two tech giants and discuss the complexities of timing your entry into this pair trade. Understanding Pair Trading Pair trading is a popular strategy among institutional investors and individual traders alike. The basic idea is to identify two stocks with a strong historical correlation and buy one while selling the other. As the price of one stock moves relative to the other, you can profit from the resulting spread. The key to successful pair trading is to identify stocks with a stable correlation, as well as to develop a clear entry and exit strategy. ...

Why Ciena, Lumentum and Other Optical Stocks Were Among the Market’s Biggest Losers on Monday

Image
Why Ciena, Lumentum and Other Optical Stocks Were Among the Market’s Biggest Losers on Monday THE MONEYWISE JOURNAL  ·  finance  ·  Tuesday, October 13, 2026 Analysts suggest the tumble may be linked to recent cautious commentary regarding spending on artificial‑intelligence (AI) projec… By MoneyWise Guide On Monday, shares of optical‑technology companies such as Ciena and Lumentum fell sharply, making them some of the day’s biggest decliners on U.S. equity markets. Analysts suggest the tumble may be linked to recent cautious commentary regarding spending on artificial‑intelligence (AI) projects. Key Takeaways Ciena and Lumentum were among the biggest losers on Monday. The sharp price moves were tied to wary remarks about AI‑related spending. Both companies operate in the optical‑networking sector, which supplies the fiber‑optic hardware that carries data. Metric Value Why...

History Shows IPO Stocks Plunge Up to 48% Within 1 Year of Going Public. Here's Why SpaceX Could Defy the Odds in 2027.

Image
History Shows IPO Stocks Plunge Up to 48% Within 1 Year of Going Public. Here's Why SpaceX Could Defy the Odds in 2027. THE MONEYWISE JOURNAL  ·  finance  ·  Thursday, October 29, 2026 The discussion now turns to whether a projected 2027 IPO for SpaceX would follow the same pattern or break away thanks to a set o… By MoneyWise Guide IPO Stocks Historically Lose Up to 48% in First Year; SpaceX May Defy Trend in 2027 Analysis of almost 1,500 initial public offerings spanning three decades shows that the median decline for IPO stocks in their first twelve months can reach 48 %, while the median one‑year return sits at a negative 4.7 %. The discussion now turns to whether a projected 2027 IPO for SpaceX would follow the same pattern or break away thanks to a set of growth catalysts highlighted in recent commentary. Key Takeaways The median first‑year drawdown for IPOs over a 30‑year sample is up to 48 %. The median one‑y...

Three Dividend Stocks to Buy in October and Hold for 20 Years

Image
Three Dividend Stocks to Buy in October and Hold for 20 Years THE MONEYWISE JOURNAL  ·  finance  ·  Thursday, October 08, 2026 SKUs by 2026, and Sysco’s $29 billion purchase of Jetro Restaurant Depot are the key actions that could shape dividend returns ov… By MoneyWise Guide Kimberly‑Clark’s $48.7 billion acquisition of Kenvue, PepsiCo’s plan to eliminate nearly 20% of its U.S. SKUs by 2026, and Sysco’s $29 billion purchase of Jetro Restaurant Depot are the key actions that could shape dividend returns over the next two decades. Key Takeaways Kimberly‑Clark is adding consumer‑health brands through a $48.7 billion deal that should generate $2.1 billion in annual synergies. PepsiCo is trimming its product lineup by about 20% of U.S. SKUs to focus on high‑growth items, a move backed by activist investor Elliott. Sysco is expanding into a cash‑and‑carry wholesale model with a $29 billion acquisition, adding a ...

Wall Street braces for Fed hikes; Eli Lilly, Medtronic, J&J hold

MONEY Wall Street Braces for Fed Rate Hikes; Eli Lilly, Medtronic, and Johnson & Johnson Stand Strong Bond yields are climbing, inflation remains above the Federal Reserve’s target, and a single rate increase has already been enacted. Wall Street is preparing for additional hikes that will raise costs for companies and consumers alike, tightening household budgets. Key Takeaways Inflation stays above the Fed’s 2% target, prompting expectations of more rate hikes. Eli Lilly’s GLP‑1 drugs now represent about 66% of its revenue, yet the company is expanding into new therapeutic areas. Medtronic’s sales grew 8.4% in fiscal 2026, its fastest pace in a decade, and its dividend has risen for 49 consecutive years. Johnson & Johnson’s dividend has increased annually for over six decades, earning it Dividend King status. Metric ...

Why Surging Oil Prices Could Trigger Another Fed Rate Hike—And How to Protect Your Wealth

Image
Wall Street is bracing for impact. As global oil prices rip higher, inflation fears are resurfacing across financial markets—and investors are rapidly repricing the likelihood of the Federal Reserve raising interest rates once again. As a Certified Financial Planner with over 15 years of experience guiding clients through market cycles, economic booms, and policy shifts, I can tell you that an unexpected rate hike cycle is one of the most critical macroeconomic shifts you can face as an investor. When energy prices rise, the cost of living follows closely behind. If the Fed responds by tightening money supply further, the ripple effects will reach your mortgage, your stock portfolio, and your savings accounts. In this deep dive, we’ll analyze why oil prices are driving central bank policy, what another interest rate hike could mean for stock valuations, and—most importantly—the actionable steps you can take today to safeguard and gr...

How hedge‑fund manager Brian Kelly built Bracket22 with AI agents

Image
How hedge‑fund manager Brian Kelly built Bracket22 with AI agents THE MONEYWISE JOURNAL  ·  finance  ·  Thursday, September 10, 2026 By replacing a global staff that cost roughly $5 million a year with autonomous software agents, his annual operating expense fel… By MoneyWise Guide Brian Kelly, a former cryptocurrency hedge‑fund manager, launched Bracket22 as a fully AI‑driven trading firm in 2025. By replacing a global staff that cost roughly $5 million a year with autonomous software agents, his annual operating expense fell to between $30,000 and $40,000. Key Takeaways Kelly’s AI‑only model cuts labor‑related costs from about $5 million to under $40,000 per year. Bracket22 runs three specialized agents—Steffi, Desmond, and Houston—to handle technical analysis, quantitative strategies, and overall coordination. The firm trades only Kelly’s personal capital across cryptocurrencies, stocks, and commodities....